[Peculiarities of blood coagulation disorders in patients with COVID-19].

Natalia G Evtugina S S Sannikova Alina D Peshkova S I Safiullina I A Andrianova G R Tarasova A I Khabirova Alexander Rumiantsev Fazoil I Ataullakhanov Rustem I Litvinov

Published in: Terapevticheskii arkhiv (2021)

The results obtained substantiate the need for laboratory monitoring of hemostasis and active prophylaxis and treatment of thrombotic complications in COVID-19.

Keyphrases

coronavirus disease
sars cov
risk factors
combination therapy
respiratory syndrome coronavirus
replacement therapy